My Blog List

Saturday, 14 October 2017

Neurodegenerative Disorders Drug Development Pipeline Review, 2017

Summary:

Report Hive Market Research Released a New Research Report of 106 pages on Title “ Neurodegenerative Disorders Drug Development Pipeline Review, 2017 “with detailed Analysis, Forecast and Strategies.

Description:

Neurodegenerative disorders are a cluster of conditions that affect the central nervous system. They include both hereditary and sporadic conditions that are characterized by slow, irreversible, progressive dysfunction of the nervous system with the increasing degeneration of neurons, which causes symptoms such as motor impairment, memory loss and declining cognitive ability. Neurodegenerative disorders cannot currently be cured, and treatment is aimed at managing the disease indication in order to reduce the severity of symptoms and slow progression.
There are over 1,400 products in active development in the neurodegenerative disorders therapy area. The current market landscape consists of a number of biologics and small molecules, while the pipeline also consists of gene therapies and cell therapies, demonstrating broader pharmaceutical research and development.
Small molecule drugs dominate the pipeline, with approximately 64% of total pipeline molecules. In comparison, the number of biologics in the pipeline is much lower, representing approximately 26% of the pipeline. Overall the neurodegenerative disorders pipeline is large, with a substantial proportion of products being early-stage assets at the Preclinical development stage.
The report provides comprehensive information on the pipeline development landscape for is Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Amyotrophic lateral sclerosis and Multiple sclerosis, from Discovery through to the Pre-registration stage. This includes an analysis of products by stage of development, molecular target, mechanism of action (MoA), route of administration (RoA) and molecule type. Finally, the report provides an overview of key players involved in the development of products in this area, and outlines recent updates and press releases in the field.

Scope

- Which companies are the most active within the pipeline for neurodegenerative disorders?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in this disease area?

Reasons to buy

- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
Make an Enquiry Of report for Discount @ https://www.reporthive.com/enquiry.php?id=1089494&req_type=disc

Table of Content:

Part I Duodenoscope Industry Overview
GBI Research Report Guidance 2
Executive Summary 3
Table of Contents 4
List of Tables 6
List of Figures 25
Introduction 27
Neurodegenerative Disorders Report Coverage 27
Alzheimer’s Disease Overview 27
Amyotrophic Lateral Sclerosis Overview 27
Huntington Disease Overview 27
Multiple Sclerosis Overview 27
Parkinson’s Disease Overview 27
Therapeutics Development 28
Alzheimer’s Disease 28
Amyotrophic Lateral Sclerosis 30
Huntington Disease 32
Multiple Sclerosis 34
Parkinson’s Disease 36
Therapeutics under Development by Companies 38
Alzheimer’s Disease 38
Amyotrophic Lateral Sclerosis 50
Huntington Disease 55
Multiple Sclerosis 58
Parkinson’s Disease 68
Therapeutics under Investigation by Universities/Institutes 75
Alzheimer’s Disease 75
Amyotrophic Lateral Sclerosis 78
Huntington Disease 79
Multiple Sclerosis 81
Parkinson’s Disease 83
Pipeline Products Glance 85
Alzheimer’s Disease 85
Amyotrophic Lateral Sclerosis 88
Huntington Disease 91
Multiple Sclerosis 94
Parkinson’s Disease 97
Products under Development by Companies 101
Alzheimer’s Disease 101
Amyotrophic Lateral Sclerosis 116
Huntington Disease 120
Multiple Sclerosis 123
Parkinson’s Disease 134
Products under Investigation by Universities/Institutes 144
Alzheimer’s Disease 144
Amyotrophic Lateral Sclerosis 150
Huntington Disease 152
Multiple Sclerosis 153
Parkinson’s Disease 155
Companies Involved in Therapeutics Development 158
Alzheimer’s Disease 158
Amyotrophic Lateral Sclerosis 273
Huntington Disease 318
Multiple Sclerosis 346
Parkinson’s Disease 439
Therapeutics Assessment 531
Alzheimer’s Disease 531
Amyotrophic Lateral Sclerosis 585
Huntington Disease 607
Multiple Sclerosis 617
Parkinson’s Disease 656
Dormant Projects 684
Alzheimer’s Disease 684
Amyotrophic Lateral Sclerosis 698
Huntington Disease 702
Multiple Sclerosis 705
Parkinson’s Disease 714
Discontinued Products 723
Alzheimer’s Disease 723
Amyotrophic Lateral Sclerosis 726
Huntington Disease 726
Multiple Sclerosis 727
Parkinson’s Disease 728
Product Development Milestones 730
Alzheimer’s Disease 730
Amyotrophic Lateral Sclerosis 741
Huntington Disease 752
Multiple Sclerosis 761
Parkinson’s Disease 782
Appendix 796
Methodology 796
Coverage 796
Secondary Research 796
Primary Research 796
Expert Panel Validation 796
Contact Us 797
Disclaimer 797
Read Full Table of Contents

About Report Hive Research

We are a leading repository of market research reports and solutions catering to industries like Comm & Technology, Energy & Power, Food And Beverages, Automotive & Transportation, Healthcare & Life Science etc. This large collection of reports assists organizations in decision-making on aspects such as market entry strategies, market sizing, market share analysis, competitive analysis, product portfolio analysis and opportunity analysis among others. We also assist in determining the best suited and targeted report from our large repository of global reports, company-specific reports and country-level reports.

Contact Us

Mike Ross
Marketing Manager
mike.ross@reporthive.com
http://www.reporthive.com
Phone: +1 312–604–7084
Sainath Nagar, Vadgaon Sheri,
Pune, Maharashtra 411014